Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag A daily pill slowed type 1 diabetes progression in newly diagnosed patients, preserving insulin production.

flag A daily pill containing baricitinib, a drug used for autoimmune conditions like rheumatoid arthritis, showed promise in slowing type 1 diabetes progression in recently diagnosed patients. flag A two-year follow-up of the BANDIT trial found it preserved insulin-producing cells, stabilized blood sugar, and reduced insulin needs, but benefits stopped when the drug was discontinued. flag Researchers believe further trials may lead to a treatment that delays or prevents insulin dependence, with potential availability within five years.

9 Articles